Vaccine News and Research

Latest Vaccine News and Research

UC San Diego Library becomes official repository for the papers of Jonas Salk

The University of California, San Diego Library has become the official repository for the papers of Jonas Salk, noted physician, virologist, and humanitarian, best known for his development of the world's first successful vaccine for the prevention of polio.

21 Mar 2014

New treatment could halt progression of dementia

Researchers at the University of Texas Medical Branch at Galveston have discovered a way to potentially halt the progression of dementia caused by accumulation of a protein known as tau.

21 Mar 2014

GHIT Fund announces grants to speed up innovative drug development for neglected diseases

The Global Health Innovative Technology Fund, a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, today announced three grants worth a total of US$6.8 million to speed the development of innovative drugs for some of the world’s most neglected diseases—schistosomiasis, Chagas disease and parasitic roundworms.

20 Mar 2014

New study provides first ever reliable data on antibiotic use in non-EU countries

A new study, published in The Lancet Infectious Diseases journal, provides the first ever reliable data on antibiotic use in non-European Union southern and eastern European countries and newly independent states.

20 Mar 2014

LSTM and University of Liverpool receive GHIT Fund to target lymphatic filariasis and onchocerciasis

The Liverpool School of Tropical Medicine (LSTM) together with colleagues at the Department of Chemistry (University of Liverpool (UoL)) and Japanese pharmaceutical company Eisai are pleased to announce that they have been awarded a Global Health Innovative Technology (GHIT) Fund to develop new drugs to target lymphatic filariasis and onchocerciasis.

20 Mar 2014

Investigational vaccine reduces number of tumors in mice with lung cancer

Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted the immune response and reduced the number of tumors in mice with lung cancer.

20 Mar 2014

Tamiflu cuts H1N1 pandemic deaths by 25%, shows study

Adults hospitalised with H1N1 influenza during the 2009–2010 pandemic were 25% less likely to die from the disease if they were given antiviral drugs called neuraminidase inhibitors (NAIs) such as Tamiflu, according to a large meta-analysis involving more than 29 000 patients from 38 countries, published in The Lancet Respiratory Medicine journal. The findings also indicate that treatment within 2 days of flu symptoms developing halved the risk of death compared with later treatment or no treatment.

20 Mar 2014

VaxInnate starts Phase 1 clinical trial to evaluate VAX2012Q for prevention of seasonal influenza

VaxInnate Corporation today announced that enrollment has commenced in a Phase 1 clinical trial to evaluate VAX2012Q, a recombinant quadrivalent vaccine in development for the prevention of seasonal influenza. VaxInnate is a biotechnology firm pioneering a breakthrough technology platform for the development of novel vaccines.

20 Mar 2014

CLL patients more prone to infections due to reduced number of antibodies

People with chronic lymphocytic leukaemia (CLL) are essentially more prone to infections such as varicella, influenza or pneumococci due to the reduction in the number of antibodies that their condition causes.

19 Mar 2014

Dartmouth, Aeras to jointly conduct trial of DAR-901 vaccine against TB

Dartmouth's Geisel School of Medicine and Aeras, a global nonprofit biotech, announced a collaboration to jointly conduct a trial of a new vaccine against tuberculosis (TB), one of the world's deadliest diseases. The vaccine, known as DAR-901, is related to the vaccine SRL-172, previously shown by Dartmouth investigators to decrease the risk of TB in a trial known as the DarDar Trial.

19 Mar 2014

Playing science-based mobile gaming app for 25 minutes can reduce anxiety

Playing a science-based mobile gaming app for 25 minutes can reduce anxiety in stressed individuals, according to research published in Clinical Psychological Science, a journal of the Association for Psychological Science.

19 Mar 2014

UCLA creates new program that helps adoptive parents, children navigate through international adoption process

With thousands of internationally adopted children arriving in the United States each year, there is a growing demand for a specialized health-care support system that helps adoptive parents and children navigate through the international adoption process.

19 Mar 2014

Uptake for HPV jab below 80% required to make significant impact on cervical cancer

Young women who are most at risk of developing cervical cancer are the least likely to be offered the protective HPV jab and to complete the full course when they are, reveals research published online in the journal Sexually Transmitted Infections.

18 Mar 2014

UC baby health innovation wins Gates award

An innovative, colourful and accessible design to improve child health records worldwide has earned a University of Canberra graphic design lecturer a prestigious international award.

17 Mar 2014

MD Anderson collaborates with MedImmune to develop therapies that unleash patients' immune systems to attack cancers

The University of Texas MD Anderson Cancer Center and MedImmune, the global biologics research and development arm of AstraZeneca, will collaborate through MD Anderson's Moon Shots Program to develop therapies that unleash patients' immune systems to attack their cancers.

14 Mar 2014

Australians it's time to consider a flu vaccination

Although it is still early in the season, NPS MedicineWise is joining other health experts in recommending that people at risk of complications of the flu (influenza) get vaccinated against the illness.

13 Mar 2014

Two synergistic therapies allow solid tumors to act as their own cancer-fighting vaccine

Researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute eradicated solid tumors in laboratory mice using a novel combination of two targeted agents. These two synergistic therapies stimulate an immune response, ultimately allowing solid tumors to act as their own cancer-fighting vaccine.

13 Mar 2014

Women who experience gestational diabetes may face increased risk of heart disease later in life

Women who experience gestational diabetes may face an increased risk of early heart disease later in life, even if they do not develop type 2 diabetes or metabolic syndrome subsequent to their pregnancy, according to a Kaiser Permanente study published today in the Journal of the American Heart Association.

13 Mar 2014

Teen researcher wins top award from Intel Foundation for research on potential drugs to treat influenza

From new cancer treatments to an exploration of how technology affects the adolescent brain, the innovative research of America's future scientists, engineers and inventors took center stage in the nation's capital today.

12 Mar 2014

One person's unique ability provides key insights into immune response to fight HIV

One person's unique ability to fight HIV has provided key insights into an immune response that researchers now hope to trigger with a vaccine, according to findings reported by a team that includes Duke Medicine scientists.

11 Mar 2014

Vaccine News and Research

Latest Vaccine News and Research

UC San Diego Library becomes official repository for the papers of Jonas Salk

New treatment could halt progression of dementia

GHIT Fund announces grants to speed up innovative drug development for neglected diseases

New study provides first ever reliable data on antibiotic use in non-EU countries

LSTM and University of Liverpool receive GHIT Fund to target lymphatic filariasis and onchocerciasis

Investigational vaccine reduces number of tumors in mice with lung cancer

Tamiflu cuts H1N1 pandemic deaths by 25%, shows study

VaxInnate starts Phase 1 clinical trial to evaluate VAX2012Q for prevention of seasonal influenza

CLL patients more prone to infections due to reduced number of antibodies

Dartmouth, Aeras to jointly conduct trial of DAR-901 vaccine against TB

Playing science-based mobile gaming app for 25 minutes can reduce anxiety

UCLA creates new program that helps adoptive parents, children navigate through international adoption process

Uptake for HPV jab below 80% required to make significant impact on cervical cancer

UC baby health innovation wins Gates award

MD Anderson collaborates with MedImmune to develop therapies that unleash patients' immune systems to attack cancers

Australians it's time to consider a flu vaccination

Two synergistic therapies allow solid tumors to act as their own cancer-fighting vaccine

Women who experience gestational diabetes may face increased risk of heart disease later in life

Teen researcher wins top award from Intel Foundation for research on potential drugs to treat influenza

One person's unique ability provides key insights into immune response to fight HIV

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in